Product Information
RETIN-A 0.01% GEL is a brand product labeled by Bausch Health US LLC, priced at $0.9600 per GM under NDC 00187517215. Its NADAC has been published 77 times since Apr 17, 2024.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.1 mg/g
Manufacturer
Bausch Health US LLCNDC
00187517215
Classification
Brand
Dosage Form
GEL
Route
TOPICAL
Effective Date
9/17/2025
Active Ingredients
TRETINOINApproval Type
New Drug (NDA)
FDA Application
NDA017955FDA Approved
Before 1982
TE Code
AB
On Market Since
7/30/1979
Pharmacological Classes
Price Statistics
The NADAC for RETIN-A 0.01% GEL has been published 77 times since Apr 17, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9600 per GM |
|---|---|
| All-time high | $0.9615 (Jan 15, 2025) |
| All-time low | $0.9574 (Jul 17, 2024) |
| 52-week high | $0.9602 |
| 52-week low | $0.9600 |
| Median price | $0.9606 |
| Average price | $0.9600 |
| Largest weekly change | +0.3% (Aug 21, 2024) |
| Weeks tracked | 77 |
| Tracking since | Apr 17, 2024 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-0.0%
3Y
N/A
5Y
N/A
All
+0.2%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RETIN-A 0.01% GEL?
The current National Average Drug Acquisition Cost (NADAC) for RETIN-A 0.01% GEL, manufactured by Bausch Health US LLC, is $0.9600 per GM (NDC 00187517215), effective Oct 1, 2025.
How has the price of RETIN-A 0.01% GEL changed over time?
Over the history we have for it, the NADAC for RETIN-A 0.01% GEL has held within roughly two percent of its current level. It has been tracked across 77 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for RETIN-A 0.01% GEL?
Since Apr 17, 2024, the NADAC for RETIN-A 0.01% GEL has ranged from a low of $0.9574 (Jul 17, 2024) to a high of $0.9615 (Jan 15, 2025), with a median of $0.9606 per GM.
Are there cheaper alternatives to RETIN-A 0.01% GEL?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RETIN-A 0.01% GEL, is $0.9570 per GM — about 0% below RETIN-A 0.01% GEL.
Who manufactures RETIN-A 0.01% GEL?
RETIN-A 0.01% GEL (NDC 00187517215) is labeled by Bausch Health US LLC, and CMS classifies it as a brand product.